Skip to main content

Open Access Triterpenoid saponins and anti-inflammatory activity of Codonopsis lanceolata

The ethanolic root extract of Codonopsis lanceolata were evaluated for anti-inflammatory activity using the carrageenan induced rat hind paw edema model and displayed a significant activity of 51.82% inhibition at 200 mg/kg at 3 h (p < 0.05). Further isolation of the extract yielded two new triterpenoid saponins, named codonolaside I (1) and codonolaside II (2). The spectroscopic and chemical data revealed their structures to be 3-O-[β-D-xylopyranosyl (1→3)-(6′-O-methyl)-β-D-glucuronopyranosyl]-3β, 16α-dihydroxyolean-12-ene-28-oic acid 28-O-[β-D-xylopyranosyl (1→4)-α-L-rhamnpyranosyl (1→2)-α-L-arabinopyranosyl] ester (1), and 3β, 16α-dihydroxyolean-12-ene-28-oic acid 28-O- [β-D-xylopyranosyl (1→3)-β-D-xylopyranosyl (1→4)-α-L-rhamnpyranosyl (1→2)-α-L-arabinopyranosyl] ester (2).

Document Type: Research Article

Affiliations: 1: School of Pharmacy, Changchun College of Traditional Chinese Medicine, Changchun, People's Republic of China 2: School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, People's Republic of China 3: School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, 110016, People's Republic of China, Email: [email protected]

Publication date: June 1, 2007

More about this publication?
  • Pharmazie is a leading journal in the field of pharmaceutical sciences. As a peer-reviewed scientific journal, Pharmazie is regularly indexed in the relevant databases like Web of science, Journal Citation Reports and many others. The journal is open for submissions from the whole spectrum of pharnaceutical sciences including Pharmaceutical Chemistry, Experimental and Clinical Pharmacology, Drug Analysis, Pharmaceutics, Pharmaceutical Biology, Clinical Pharmacy etc.
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content